MORGAN STANLEY PLC/CALL/EDWARDS LIFESCIENCES/120/0.1/21.06.24 Stock

Warrant

DE000MB8GN49

Market Closed - Börse Stuttgart 02:59:19 2024-05-31 pm EDT
0.043 EUR +2.38% Intraday chart for MORGAN STANLEY PLC/CALL/EDWARDS LIFESCIENCES/120/0.1/21.06.24
1 month+86.96%
3 months+30.30%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-31 0.043 +2.38%
24-05-30 0.042 -2.33%
24-05-29 0.043 +95.45%
24-05-28 0.022 +10.00%
24-05-27 0.02 -4.76%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 02:59 pm EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying EDWARDS LIFESCIENCES CORPORATION
Issuer Morgan Stanley
WKN MB8GN4
ISINDE000MB8GN49
Date issued 2023-07-07
Strike 120 $
Maturity 2024-06-21 (19 Days)
Parity 10 : 1
Emission price 0.27
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.3
Lowest since issue 0.013
Delta0x
Omega 0.000000
Premium0x
Gearing282.4x
Moneyness 1.162
Difference Strike 33.11 $
Difference Strike %+27.59%
Spread 0.005
Spread %10.42%
Intrinsic value 1.787
Present value -1.741926

Company Profile

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (67.9%); - hemodynamic monitoring systems (15.5%); - other (16.6%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
More about the company

Ratings for Edwards Lifesciences Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Edwards Lifesciences Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
86.89 USD
Average target price
96.55 USD
Spread / Average Target
+11.12%
Consensus